Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD. [PDF]
World Allergy Organ J, 2023 Tepetam FM +4 more
europepmc +1 more source
Stories and Communication Behaviors in Conflict. [PDF]
Behav Sci (Basel)Ron Y.
europepmc +1 more source
Aspirin-exacerbated respiratory disease: Updates in the era of biologics. [PDF]
Ann Allergy Asthma Immunol, 2023 Mullur J, Buchheit KM.
europepmc +1 more source
Diagnosis and acute management of type A aortic dissection. [PDF]
Br J Cardiol, 2023 Acharya M, Mariscalco G.
europepmc +1 more source
Significance of Bishop score in single vs. double balloon catheterization for induction in labor; a meta-analysis. [PDF]
Front SurgWang P, Hu Y, Shan T, Fang F.
europepmc +1 more source
Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)? [PDF]
Front Allergy, 2023 Van Broeck D +3 more
europepmc +1 more source
HYBRID FINANCIAL INSTRUMENTS AND ANTI-HYBRID RULES IN THE EU ATAD (ARTICLE 9 ATAD)
, 2020 openaire +2 more sources
Oral and intranasal aspirin desensitisation for non-steroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease. [PDF]
Cochrane Database Syst RevLourijsen E +3 more
europepmc +1 more source
Clinical and mechanistic advancements in aspirin exacerbated respiratory disease. [PDF]
J Allergy Clin ImmunolElahi S, Peters AT, Kato A, Stevens WW.
europepmc +1 more source